SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017352
Filing Date
2023-05-15
Accepted
2023-05-15 16:12:50
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2082235
2 ex31-1.htm EX-31.1 11357
3 ex31-2.htm EX-31.2 11406
4 ex32-1.htm EX-32.1 6488
  Complete submission text file 0001493152-23-017352.txt   11776968

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ther-20230331.xsd EX-101.SCH 72187
6 XBRL CALCULATION FILE ther-20230331_cal.xml EX-101.CAL 75867
7 XBRL DEFINITION FILE ther-20230331_def.xml EX-101.DEF 391660
8 XBRL LABEL FILE ther-20230331_lab.xml EX-101.LAB 628050
9 XBRL PRESENTATION FILE ther-20230331_pre.xml EX-101.PRE 488810
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1694010
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 23922397
SIC: 2834 Pharmaceutical Preparations